The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Eversmile IPR Glide
2.7% Sodium Fluoride Gel · SODIUM FLUORIDE 27 mg/mL · Gel · Dental · Everbrands, Inc. dba Everpure, Inc.
NDC 72655-0400-01 · 1 SYRINGE, PLASTIC in 1 BOX / 4 mL in 1 SYRINGE, PLASTIC · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for sodium fluoride (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of 2.7% Sodium Fluoride Gel (Gel)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Everbrands, Inc. dba Everpure, Inc. | SODIUM FLUORIDE 27 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Eversmile IPR Glide — NDC 72655-0400-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72655040001.
Free to cite with attribution — see how the data is put together.